PennantPark投资 PNNT 深 沪
已收盘 07-02 16:00:00 美东时间
3.45
-0.050
-1.43%
华盛通- 最 高3.545
- 今 开3.52
- 成交量 74.33万股
- 最 低 3.41
- 昨 收 3.50
- 总市值 2.25亿
- 52周最高 6.65
- 市盈率 静 6.88
- 换手率 1.14%
- 52周最低 3.295
- 委 比 0.36%
- 总股本 6529.61万
- 历史最高 6.65
- 量 比 0.82
- 振 幅 3.86%
- 历史最低 -2.835
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PennantPark Investment declares $0.08 dividend
PennantPark Investment (PNNT) declares $0.08/share monthly dividend, in line with previous. Forward yield 27.83% PennantPark Investment Corporation (PNNT) declares a $0.04 per share base dividend and...
07-03 04:20
PennantPark Investment Announces June 2026 Monthly Distribution
An announcement from Pennantpark Investment ( ($PNNT) ) is now available. On Ju...
06-03 05:46
PennantPark declares $0.0833 dividend
PennantPark (PFLT) declares $0.0833/share monthly dividend, in line with previous. Forward yield 11.99% PennantPark Investment Corporation (PNNT) declares a $0.08 per share base dividend and $0.0033 ...
06-03 04:16
PennantPark Floating Rate Capital Ltd. Prices Public Offering of $100 Million 7.375% Notes due 2031
PennantPark Floating Rate Capital Ltd. has priced an underwritten public offering of $100 million aggregate principal amount of its 7.375% notes due 2031. The notes will mature on June 15, 2031, and may be redeemed at the company's option starting June 15, 2028. The offering is expected to close on June 1, 2026, with the notes listed on the New York Stock Exchange under the symbol "PFLA." The company has granted underwriters a 30-day option to pu...
05-27 21:45
美股大行评级 | 最高1100美元，花旗、瑞穗、 Melius Research齐上调美光目标价；X-Energy获大小摩等多家机构首予“买入”评级
今日重点评级关注：TD Cowen：维持Strategy"买入"评级，目标价从395美元升至400美元；摩根士丹利：维持Cipher Digital"超配"评级，目标价从40.5美元升至42.5美元
05-20 11:55
Truist Securities Maintains Buy on Pennant Park Investment, Lowers Price Target to $5
Truist Securities analyst Arren Cyganovich maintains Pennant Park Investment (NYSE:PNNT) with a Buy and lowers the price target from $6 to $5.
05-20 02:27
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Oppenheimer Maintains Perform on Pennant Park Investment, Lowers Price Target to $5
Oppenheimer analyst Mitchel Penn maintains Pennant Park Investment (NYSE:PNNT) with a Perform and lowers the price target from $6 to $5.
05-13 01:40
PennantPark Investment Balances NAV Hit With JV Strength
Pennantpark Investment (($PNNT)) has held its Q2 earnings call. Read on for the...
05-09 09:59
PennantPark Investment declares $0.08 dividend
PennantPark Investment (PNNT) declares $0.08/share monthly dividend, in line with previous. It comprised of a $0.04 per share base dividend and $0.04 per share supplemental dividend. Payable June 1; f...
05-05 14:31
